Frankfurt - Start of a new trial site

On 27 March 2026, the University Hospital Frankfurt became officially an active trial site of the STOP-PKD Study.

Dr. Jeannine Lang´s team cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Frankfurt to obtain detailed information about the trail and potential participation.

Phone: +49 696301 5320

Email: Studien.Nephrologie@unimedizin-ffm.de